Pure Global
NCT06409260

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Objective Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography: A Randomized Study
Matias Vested·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Blockade
Drug/Device/Intervention
Acceleromyography (AMG)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Matias Vested
Funder
Rigshospitalet, Denmark
Location
Copenhagen, Denmark
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jul 01, 2025
Enrollment
120 participants
Primary outcome

Time from injection of rocuronium until appearance of the first TOF ratio ≥ 90

Summary

The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime
 TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age
 of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n.
 tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to
 return to TOF 90%) from neuromuscular block than EMG.

ICD-10 classifications
Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409260
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06409260 through Pure Global AI's free database. This phase not specified trial is sponsored by Matias Vested and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.